Jothi Murali, MD
Orthopedic Surgery · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 29
- 6 carriers
- Offices
- 3
Offices
3 locations · UCSF Medical Group Business Services · 1,533 clinicians in this group
Hospitals listed: El Camino Health · Good Samaritan Hospital · Washington Hospital. That is not proof they admit you there this week.
Plans that list them
29 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Murali’s office at (408) 364-1673 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
29 of 29 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A125346 · Current
Licensed to practise in California · since 2013 · expires 2027-01-31 · Emory University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$86,066
Medicare paid this office $86,066 for 131 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 78 | $21,298 | $117 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 15 | $7,463 | None |
| Aspiration and/or injection of fluid from large joint | 33 | $6,323 | $54 |
| New patient visit (45+ min) | 42 | $5,821 | $139 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $3,998 | $138 |
See all 11 services
| Return visit (30+ min) | 78 | $21,298 | $117 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 15 | $7,463 | None |
| Aspiration and/or injection of fluid from large joint | 33 | $6,323 | $54 |
| New patient visit (45+ min) | 42 | $5,821 | $139 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $3,998 | $138 |
| Injection of drug or substance under skin or into muscle | 37 | $1,371 | $14 |
| Measurement of range of motion in arm, leg or each spine section | 23 | $770 | $21 |
| Mri scan of arm joint without contrast | 11 | $636 | $58 |
| X-ray of knee, 4 or more views | 18 | $284 | $10 |
| Injection, dexamethasone sodium phosphate, 1 mg | 28 | $15 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 26 | $1 | None |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
| Knee replacement | 1-10 | None |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Removal of tissue | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Who their Medicare patients are
131 Original Medicare patients in 2024. Average age 76 · Women 74% · Also on Medicaid 32% · Health risk score 1.21. Above the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 34% · Coronary heart disease 26% · Chronic kidney disease 24% · Heart failure 19% · Atrial fibrillation 18% · Depression 18% · Dementia 15% · Cancer 11% · Stroke 10% · COPD 9%.
The office billed $454,772, Medicare allowed $111,680 and paid $86,066; for 971 services of 66 kinds; $7,479 of it was for drugs given in the office and $78,587 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 131 | 971 | 76 | 1.21 | $454,772 | $86,066 |
| 2023 | 134 | 1,233 | 77 | 1.16 | $507,362 | $98,298 |
| 2022 | 103 | 831 | 76 | 1.54 | $309,080 | $69,477 |
| 2021 | 107 | 834 | 75 | 1.16 | $385,351 | $68,613 |
| 2020 | 102 | 740 | 77 | 1.19 | $441,041 | $70,246 |
| 2019 | 128 | 629 | 77 | 1.50 | $428,844 | $86,519 |
| 2018 | 83 | 301 | 77 | 1.79 | $242,936 | $47,469 |
| 2017 | 29 | 125 | 73 | 0.87 | $41,829 | $7,261 |
| 2016 | 201 | 1,760 | 73 | 1.27 | $180,771 | $62,005 |
| 2015 | 345 | 2,671 | 76 | 1.29 | $330,961 | $125,043 |
| 2014 | 140 | 546 | 75 | 1.20 | $131,265 | $47,927 |
| 2013 | 24 | 44 | 72 | 1.59 | $79,285 | $16,655 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Return visit (30+ min) | 85 | $26,689 | $116 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 17 | $10,168 | None |
| New patient visit (45+ min) | 55 | $8,156 | $148 |
| Aspiration and/or injection of fluid from large joint | 38 | $7,889 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,330 | $151 |
| Injection of drug or substance under skin or into muscle | 46 | $1,630 | $14 |
| Measurement of range of motion in arm, leg or each spine section | 17 | $726 | $19 |
| Mri scan of arm joint without contrast | 11 | $649 | $59 |
| X-ray of knee, 4 or more views | 19 | $318 | $10 |
| X-ray of hip, minimum of 4 views | 11 | $218 | $11 |
| Injection, dexamethasone sodium phosphate, 1 mg | 32 | $18 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 33 | $1 | None |
2022: 11 services
| Short return visit (20+ min) | 50 | $9,598 | $81 |
| New patient visit (45+ min) | 41 | $6,120 | $149 |
| Return visit (30+ min) | 34 | $5,912 | $123 |
| Aspiration and/or injection of fluid from large joint | 27 | $4,849 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,942 | $163 |
| Injection of drug or substance under skin or into muscle | 28 | $1,070 | $14 |
| Measurement of range of motion in arm, leg or each spine section | 16 | $516 | $20 |
| X-ray of knee, 4 or more views | 17 | $243 | $10 |
| X-ray of shoulder, minimum of 2 views | 12 | $183 | $10 |
| Injection, dexamethasone sodium phosphate, 1 mg | 23 | $14 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 24 | $1 | None |
2021: 12 services
| Return visit (30+ min) | 48 | $9,645 | $124 |
| New patient visit (45+ min) | 54 | $7,448 | $138 |
| Short return visit (20+ min) | 48 | $6,719 | $78 |
| Aspiration and/or injection of fluid from large joint | 28 | $2,955 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,950 | $174 |
| Measurement of range of motion in arm, leg or each spine section | 20 | $801 | $22 |
| Injection of drug or substance under skin or into muscle | 29 | $613 | $14 |
| X-ray of knee, 4 or more views | 19 | $361 | $10 |
| X-ray of shoulder, minimum of 2 views | 16 | $279 | $9 |
| X-ray of hip, minimum of 4 views | 11 | $202 | $13 |
| Injection, dexamethasone sodium phosphate, 1 mg | 24 | $17 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 25 | $1 | None |
2020: 11 services
| New patient visit (45+ min) | 49 | $7,039 | $144 |
| Short return visit (20+ min) | 38 | $4,265 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,640 | $182 |
| Return visit (30+ min) | 21 | $3,164 | $105 |
| Aspiration and/or injection of fluid from large joint | 23 | $2,098 | $55 |
| Measurement of range of motion in arm, leg or each spine section | 24 | $1,214 | $22 |
| Injection of drug or substance under skin or into muscle | 26 | $494 | $14 |
| X-ray of knee, 4 or more views | 12 | $253 | $11 |
| X-ray of shoulder, minimum of 2 views | 15 | $196 | $9 |
| Injection, dexamethasone sodium phosphate, 1 mg | 24 | $9 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 25 | $1 | None |
2019: 10 services
| Treatment of broken neck of thigh bone with bone implant | 16 | $18,257 | $1,141 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $8,976 | $180 |
| Short return visit (20+ min) | 46 | $6,062 | $70 |
| New patient visit (45+ min) | 32 | $4,740 | $148 |
| Return visit (30+ min) | 22 | $3,253 | $102 |
| Aspiration and/or injection of fluid from large joint | 16 | $1,714 | $63 |
| Measurement of range of motion in arm, leg or each spine section | 29 | $1,073 | $21 |
| Manual muscle testing of hand | 11 | $674 | $32 |
| X-ray of knee, 4 or more views | 11 | $147 | $9 |
| Injection, dexamethasone sodium phosphate, 1 mg | 12 | $2 | None |
2018: 4 services
| Return visit (30+ min) | 29 | $4,776 | $102 |
| New patient visit (45+ min) | 28 | $3,936 | $141 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,455 | $182 |
| Aspiration and/or injection of fluid from large joint | 16 | $1,266 | $55 |
2017: 3 services
| Return visit (30+ min) | 17 | $3,076 | $99 |
| New patient visit (45+ min) | 19 | $2,651 | $140 |
| Aspiration and/or injection of fluid from large joint | 11 | $882 | $49 |
2016: 8 services
| Short return visit (20+ min) | 126 | $10,200 | $56 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 14 | $8,783 | None |
| New patient visit (30+ min) | 74 | $5,825 | $79 |
| Aspiration and/or injection of fluid from large joint | 57 | $3,295 | $40 |
| X-ray of shoulder, minimum of 2 views | 22 | $784 | $24 |
| X-ray of knee, 4 or more views | 21 | $780 | $34 |
| X-ray of hip, 2-3 views | 16 | $709 | $34 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 53 | $359 | None |
2015: 15 services
| Short return visit (20+ min) | 244 | $30,766 | $62 |
| New patient visit (30+ min) | 121 | $11,141 | $92 |
| Aspiration and/or injection of fluid from large joint | 85 | $7,989 | $48 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,529 | $118 |
| X-ray of shoulder, minimum of 2 views | 51 | $2,798 | $26 |
| X-ray of wrist, 2 views | 31 | $2,017 | $26 |
| X-ray of knee, 4 or more views | 50 | $1,891 | $34 |
| Application of elbow to finger cast | 14 | $1,492 | $79 |
| New patient visit (15+ min) | 29 | $1,431 | $49 |
| Injection into tendon at attachment to bone or muscle | 12 | $875 | $51 |
| X-ray of knee, 1-2 views | 15 | $843 | $23 |
| X-ray of ribs of one side of body, minimum of 2 views | 21 | $837 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 88 | $708 | None |
| X-ray of lower and sacral spine, 2-3 views | 21 | $639 | $30 |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 16 | $621 | $15 |
2014: 11 services
| Short return visit (20+ min) | 56 | $5,492 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,059 | $118 |
| New patient visit (15+ min) | 45 | $2,997 | $67 |
| Aspiration and/or injection of fluid from large joint | 17 | $1,545 | $50 |
| Short return visit | 15 | $751 | $40 |
| X-ray of wrist, 2 views | 13 | $751 | $30 |
| New patient visit (10+ min) | 15 | $588 | $39 |
| X-ray of ribs of one side of body, minimum of 2 views | 16 | $551 | $29 |
| X-ray of knee, 1-2 views | 15 | $505 | $28 |
| X-ray of shoulder, minimum of 2 views | 12 | $473 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $97 | None |
Medicaid work
$130 in 2023
Medicaid paid $130 for 179 billed services this clinician did in 2023, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 165 | $130 |
| New patient visit (45+ min) | 14 | $0 |
| 2023 | 179 | 2 | 18 | $130 |
| 2022 | 15 | 1 | 13 | $0 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 15 | $0 |
Drugs they prescribed that Part D paid
$2,704
Pharmacies billed $2,704 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 48% of their Part D prescriptions (60 of 124) in 2024. Above the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
121 generic and fewer than 11 brand-name prescriptions · $2,704 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 41 | $286 | $7 |
| Ibuprofen | 22 | $176 | $8 |
| Gabapentin | 13 | $68 | $5 |
Year by year
| 2024 | 124 | 41 | 48% (60) | None | $2,704 |
| 2023 | 97 | 35 | 41% (40) | 0% | $882 |
| 2022 | 67 | 31 | 60% (40) | None | $3,095 |
| 2021 | 113 | 40 | 74% (84) | None | $2,518 |
| 2020 | 45 | 19 | 60% (27) | None | $334 |
| 2019 | 33 | 15 | 55% (18) | None | $676 |
| 2016 | 64 | 35 | 80% (51) | None | $1,161 |
| 2015 | 124 | 59 | 61% (76) | 15% | $5,215 |
| 2014 | 56 | 35 | 55% (31) | None | $1,186 |
| 2013 | 17 | 13 | 71% (12) | 0% | $144 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Ibuprofen | 25 | $227 | $9 |
| Hydrocodone-Acetaminophen | 29 | $183 | $6 |
| Celecoxib | 12 | $159 | $13 |
2022: 1 drug
| Hydrocodone-Acetaminophen | 27 | $288 | $11 |
2021: 1 drug
| Hydrocodone-Acetaminophen | 68 | $697 | $10 |
2020: 1 drug
| Hydrocodone-Acetaminophen | 23 | $193 | $8 |
2019: 1 drug
| Hydrocodone-Acetaminophen | 12 | $88 | $7 |
2016: 3 drugs
| Hydrocodone-Acetaminophen | 24 | $388 | $16 |
| Oxycodone-Acetaminophen | 12 | $307 | $26 |
| Tramadol | 12 | $48 | $4 |
2015: 4 drugs
| Voltaren | 14 | $1,744 | $125 |
| Oxycodone-Acetaminophen | 27 | $1,290 | $48 |
| Hydrocodone-Acetaminophen | 31 | $655 | $21 |
| Tramadol | 12 | $28 | $2 |
2014: 1 drug
| Hydrocodone-Acetaminophen | 20 | $247 | $12 |
Money from drug and device companies
$13,564 in 2025
| 2025 | 2 | 25 | $10,000 | $13,564 |
| 2024 | 3 | 21 | $1,250 | $3,681 |
| 2023 | 2 | 32 | $3,250 | $5,991 |
| 2022 | 2 | 25 | None | $5,832 |
| 2021 | 5 | 11 | None | $3,243 |
| 2020 | 4 | 6 | None | $1,871 |
| 2019 | 16 | 35 | None | $7,107 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Arthrex | None | $12,730 | 21 payments
|
| Evolution Surgical | None | $834 | 4 payments
|
See all 25 published payments
| Arthrex | Paid to speak or teach · 2025-11-06 | None | $10,000 |
| Arthrex | Travel · 2025-10-30 | None | $124 |
| Arthrex | Meals · 2025-10-25 | None | $34 |
| Arthrex | Meals · 2025-10-25 | None | $10 |
| Arthrex | Travel · 2025-10-25 | None | $244 |
| Evolution Surgical | Meals · 2025-10-24 | None | $96 |
| Arthrex | Meals · 2025-10-24 | None | $10 |
| Arthrex | Meals · 2025-10-24 | None | $34 |
| Arthrex | Meals · 2025-10-24 | None | $40 |
| Arthrex | Travel · 2025-10-24 | None | $244 |
| Arthrex | Travel · 2025-10-23 | None | $244 |
| Arthrex | Travel · 2025-08-20 | None | $557 |
| Arthrex | Travel · 2025-08-20 | None | $35 |
| Arthrex | Travel · 2025-08-20 | None | $35 |
| Evolution Surgical | Travel · 2025-07-15 | None | $586 |
| Evolution Surgical | Travel · 2025-07-15 | None | $16 |
| Arthrex | Meals · 2025-04-18 | None | $44 |
| Arthrex | Meals · 2025-04-18 | None | $25 |
| Evolution Surgical | Meals · 2025-04-17 | None | $135 |
| Arthrex | Meals · 2025-04-17 | None | $55 |
| Arthrex | Meals · 2025-04-17 | None | $25 |
| Arthrex | Meals · 2025-04-17 | None | $44 |
| Arthrex | Travel · 2025-04-17 | None | $438 |
| Arthrex | Travel · 2025-04-16 | None | $438 |
| Arthrex | Meals · 2025-03-31 | None | $48 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,681
| Arthrex | Arthroplasty Implants Anatomic Total Shoulder Eclipse | $2,945 | 14 payments
|
| Evolution Surgical | None | $709 | 6 payments
|
| DePuy Synthes Sales | Tfn-Advance | $27 | 1 payment
|
2023: $5,991
| Arthrex | Distal Extremities Implants Trauma | $5,498 | 28 payments
|
| Evolution Surgical | None | $492 | 4 payments
|
2022: $5,832
| Arthrex | None | $4,424 | 15 payments
|
| Evolution Surgical | None | $1,408 | 10 payments
|
2021: $3,243
| Evolution Surgical | None | $2,464 | 4 payments
|
| Stryker | Aequalis | $350 | 3 payments
|
| Tissuetech | Neox | $185 | 1 payment
|
| Medacta USA | Gmk Sphere | $122 | 2 payments
|
| Heron Therapeutics | Zynrelef | $122 | 1 payment
|
2020: $1,871
| Evolution Surgical | None | $1,796 | 2 payments
|
| Stryker | Mako | $44 | 2 payments
|
| Smith+Nephew | Stravix | $18 | 1 payment
|
| Ermi | None | $12 | 1 payment
|
2019: $7,107
| Evolution Surgical | None | $2,800 | 4 payments
|
| Arthrex | None | $1,808 | 6 payments
|
| Stryker | Adapt | $1,303 | 7 payments
|
| Smith+Nephew | Regeneten | $197 | 2 payments
|
| Wright Medical Technology | Blueprint Psi System | $153 | 2 payments
|
| DePuy Synthes Sales | VA-Lcp Plates & Screws | $153 | 3 payments
|
| Pacira Pharmaceuticals | Exparel | $131 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $125 | 1 payment
|
| Radius Health | Tymlos | $125 | 1 payment
|
| Osiris Therapeutics | Stravix | $123 | 1 payment
|
| Boston Scientific | General Therapies | $110 | 1 payment
|
| Zimmer Biomet Holdings | Biomet Orthopak | $19 | 1 payment
|
| Fidia Pharma USA | Hymovis | $18 | 1 payment
|
| Bioventus | Exogen | $15 | 1 payment
|
| Arthrosurface | Hemicap Wrist | $14 | 1 payment
|
| Dynasplint Systems | Dynasplint | $13 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1588866602
- Licence
- CA A125346California A125346: Current · expires 2027-01-31
- Trained
- Emory University School of Medicine, 2007
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 429 Llewellyn Ave, Campbell, CA, 95008
- NPI first listed
- 2007-06-01
- NPI last updated
- 2022-07-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 850 Brewster Ave Ste 150, Redwood City, CA, 94063 · 2405 Shadelands Dr, Walnut Creek, CA, 94598